Androgen ablation therapy is a viable treatment modality for patients with primary hormone (androgen)-dependent prostate cancer, lowering the serum androgen level and blocking androgen receptor (AR)-mediated signal transduction [2,3]. Here, AR is linked to prostate carcinoma.